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Abstract: The aim of present study is to investigate pretreatment with hydroalcoholic extract of 
Alpinia officinarum rhizome on the severity of epilepsy and memory impairment in rat. In this 
experimental study, rats were randomly assigned to seven groups. Control group and negative control 
group were intraperitoneally injected with normal saline and PTZ, respectively, for 10 days. The 
intervention groups received A. officinarum extract at different doses (50, 100 and 150 mg/kg) 30 
minutes before PTZ injection. A. officinarum extract treatment in rats with PTZ-induced kindling 
exerted significant increase in seizure latency and significant decrease in the frequency of total body 
seizure, frequent spinning, and jumping. Flumazenil significantly inhibited the antiepileptic effects of 
A. officinarum extract in the rat receiving the extract at 150 mg/kg. A. officinarum extract can inhibit 
PTZ-induced seizure and memory impairment, and therefore can be considered as a potent agent which 
warranted further research to clarify its effects. 
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1. Introduction 
Epilepsy refers to a spectrum of chronic neurological disorders characterized by epileptic seizures. 
These attacks may be very mild and undiagnosable or long-term with severe trembling. About 1% of 
the world population (65 million) suffers from epilepsy, approximately 80% of whom live in 
developing countries.  The hippocampus is one of the major regions of the brain involved in epilepsy 
and plays an important role in the learning process and memory, especially in acquiring spatial memory. 
Lesions in the region cause memory loss and spatial memory impairment [1]. The frequent incidence 
of epileptic seizures significantly declines learning rate and memory in patients with epilepsy. It has 
been demonstrated that pentylenetetrazol (PTZ)-induced chemical kindling can lead to learning 
disorders in laboratory animals. The hippocampus is not only effective on memory and learning, but 
also on the onset, generalization, and termination of seizure. The brain neurodegeneration, especially 
in the CA1 region of the hippocampus, and change in the function of changeable synapses that store 
the information, are a possible explanation of the observed learning disorder following kindling [2]. 
PTZ is a chloride channel blocker of choice that binds to the GABAA receptor complex, and is a 
chemical inducer of seizure used to study antiepileptic drugs (AEDs) in animal models. It has been 
argued that PTZ exerts adverse effects on neuronal membrane, affects potassium and calcium channels, 
releases intracellular calcium ion reserves, and reduces the neurotransmitter-induced chloride 
conductance [3]. Oxidative stress is likely to play a role in the onset and progression of epileptic 
seizures. It has been reported that epileptic seizures are associated with the hemostatic imbalance of 
antioxidants and oxidants [4]. Animal studies have indicated that PTZ-induced epileptic seizures are 
associated with significant increase in lipid peroxidation and significant decrease in the antioxidant 
activity of superoxide dismutase (SOD) and catalase (CAT) as well as glutathione levels in the red 
blood cells, liver, and brain [4,5]. The use of antioxidant compounds to cope with epileptic seizures 
has recently attracted attention and the beneficial effects of certain antioxidants have been 
demonstrated. Galangal, botanically referred to as Alpinia officinarum, is from the family 
Zingiberaceae and native to Southeast Asia and China. In Iranian traditional medicine, A. officinarum 
is used to treat common cold, to improve potency and memory, digestive disorders and stomachache, 
low back pain, rheumatism, and sciatica.  A. officinarum is also used as an emetic, anti-flatulence, and 
anti-muscle spasm agent. To date, the therapeutic effects of A. officinarum have been investigated, and 
the antioxidant [6], anti-inflammatory [7], analgesic [8], hypolipidemic [9], and antimicrobial [10] effects 
of this plant have been confirmed. Various compounds have been identified in A. officinarum rhizome 
by chromatographic techniques, including 1, 8-cineol, methyl cinnamate, galangin, 3-O-methyl 
galangin, kaempferide, alpinin, galangol, and diarylheptanoids. Galangin and 3-o-methyl galangin are 
two main compounds of A. officinarum rhizome. Galangin is a flavonoid that is found in abundance in 
A. officinarum rhizome. Galangin has different biological activities, including anti-mutagenic, anti-
oxidant, and metabolic enzyme-modulating activities. Besides that, 3-o-methyl galangin has been 
reported to exhibit hypolipidemic effects [11]. There are several methods to investigate the seizure, 
antiseizure agents and related disorder to seizure in the rodents including kindeling, tonic, clonic 
seizure and etc. In this study we aimed to evaluate the protective effect of hydroalcoholic extract of 
Alpinia officinarum rhizome on memory function as well as seizure sensevity according to the previous 
study PTZ-induced model of seizure is an appropriate paradigm to evaluate these behaviors. 
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2. Material and method 
2.1. The preparation of A. officinarum extract 
A. officinarum was purchased from a reliable grocery and botanically and systematically 
identified as A. officinarum; then, 1000 g of its dried root was dissolved in 2000 ml of 70% ethanol. 
After the solution was left at room temperature for 48 hours, it was filtered and its solvent was isolated 
in a rotary evaporator. Then, the resulting extract was completely dried at 40 °C before preparing the 
required concentrations. 
Chemicals: PTZ, diazepam and flumazenil were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
The chemical formula of diazepam and flumazenil is given below. 
                                             
1. Diazepam                                                                  2. Flumazenil 
Male Wistar rats weighing 200 ± 30 g were used in this study. The rats were caged in groups of 
10 each in the Animal House of the Shahrekord University of Medical Sciences less than 24 °C 
temperature and 12-h dark/12-h light cycle with free access to water and food. All stages of 
experimentation were carried out in accordance with the regulations of the University and the Guide 
for the Care and Use of Laboratory Animals of National Institutes of Health and Guide for the Care 
and Use of Laboratory Animals (8th edition, National Academies Press). Full efforts were made to 
diminish the use of animals and to improve their wellbeing. 
The rats were randomly assigned to seven groups of eight each as follows: 
Control group (G1) and negative control group (G2) intraperitoneally received, respectively, 
normal saline and PTZ every 48 hours for 10 days; 
Groups 3 (G3) and 4 (G4) and treatment group (G5) intraperitoneally received PTZ every 48 
hours for 10 days, and 30 minutes later, A. officinarum extract at 50, 100 and 200 mg/kg daily;  
Positive control group (G6) intraperitoneally received PTZ for 10 days, and 2 mg/kg diazepam 
on 10th day 30 minutes before PTZ treatment;  
Group 7 (G7) intraperitoneally received A. officinarum extract 30 minutes after PTZ treatment 
for 10 days and 2 mg/kg flumazenil 10 minutes before intraperitoneal treatment with 150 mg/kg A. 
officinarum on the 10th day.  
To induce epilepsy, 35 mg/kg of PTZ was intraperitoneally injected daily every 48 hours every 
other day for 9 days. 
The behavioral tests were conducted during the second 5 days. On the 10th day, 60 mg/kg of PTZ 
was administered. Injections were conducted for 10 days and the severity and rate of seizure were 
131 
AIMS Neuroscience  Volume 6, Issue 3, 128–145. 
recorded during the 30 minutes after the injection. Diazepam and flumazenil were administrated in 
single dose on the last day of the treatment. In general, after intraperitoneal injection of PTZ, the stages 
of epilepsy consist of: 
Stage 1: Head ticks; 
Stage 2: The seizure of the entire body and rearing; 
Stage 3: Tonic seizures;  
Step 4: Frequent spinning and jumping. The animal either dies or restores normal conditions after 
stage 4. All four steps do not necessarily occur and some steps may occur so quickly that they are not 
detected. 
2.2. Tail suspension test (TST) 
To conduct TST, two 70-cm metal anchors are used. The anchors are longitudinally stretched 
between two metal bases by a 50-cm rope. The animal’s tail is closed by a rope and the animal is 
hanged up from its tail. First, the rat begins to jerk and then completely becomes inactive and 
motionless. The duration of motionlessness indicates immobility time. 
2.3. Testing passive avoidance memory using shuttle box 
The shuttle box was used to test the passive avoidance memory. This apparatus includes a bright 
chamber connected to a dark chamber by a guillotine door. Electric shocks are exerted by a separate 
stimulator to the grid floor of the shuttle box. This test was performed on each rat within four days. To 
adapt to the apparatus, each rat was allowed 5 min to explore it on the first and second days. An 
acquisition test was conducted on the third day. The rats were separately left in the bright chamber, 
and after a 2-minute adaptation, the door was opened, the rats entered the dark chamber, the door was 
closed, and an electrical shock (1 mA/second) was exerted to the rats so that they only paddled. In this 
test, initial latency was considered latency to enter the dark chamber and its duration was recorded. 
Twenty four hours later, each rat was left in the bright chamber, and the interval between being left in 
the bright chamber and entering the dark chamber was measured (up to 60 seconds) and considered 
the second latency. 
2.4. Measuring the antioxidant capacity of the serum and the brain 
Three solutions were used to measure serum antioxidant capacity consisting of buffer (1.55 ml of 
sodium acetate and 8 ml of concentrated acetic acid reaching 500 ml volume using distilled water); 
iron chloride solution (270 mg of iron (III) chloride reaching 50 ml volume using distilled water; and 
triazine (47 mg of triazine dissolved in 40 ml of 40 mM hydrochloric acid).Stock solution was prepared 
by adding 10 ml of solution 1 to 1 ml of solution 2 and 1 ml of solution 3. Twenty five μl of serum 
sample or brain homogenate was added to 1.5 ml of the stock solution and the optical absorbance was 
read at 593 nm after the stock solution was left at 37 °C for 10 minutes.  
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2.5. Measurement of lipid peroxide levels in serum and brain tissues 
Two hundred μl of tissue homogenate/ serum was mixed with 1.5 ml of 20% acetic acid, 1.5 ml 
of 0.8% TBA and 200 μl of 8.1% SDS. The mixture was made up to 4 mL with distilled water and 
heated in a boiling water bath for 60 minutes. After cooling under tap water, 1 ml of distilled water 
and 5 ml of n-butanol/pyridine were added to the reaction mixtures and shaken vigorously. Then, the 
resulting solutions were centrifuged at 4000 rpm for 10 min and the optical absorbance of the 
supernatant at 532 nm was recorded. Lipid peroxide levels were determined using standard calibration 
curve and expressed as a micromol of malondialdehyde. 
2.6. Statistical analysis 
All data analysis was conducted by SPSS 16. First, Kolmogorov-Smirnov test was used to 
investigate the normality of the data distribution and Levene's test to investigate the homogeneity of 
variances. One-way analysis of variance (ANOVA) and Tukey's test were used to investigate the 
significance of difference between the treatments and mean values, respectively. Data were expressed 
as mean ± standard error, and P < 0.05 was considered significance level.  
3. Results 
3.1. Rat’s survival rate 
The survival rates in the PTZ, diazepam, PTZ + the extract (50, 100 and 150 mg/kg), and 
flumazenil groups were 50%, 100%, 90%, 100%, 100%, and 80%, respectively. Fisher's exact test 
showed a significant difference in survival rate between the groups (P < 0.001) (Figure 1). 
3.2. First seizure latency 
Treatment with A. officinarum extract (100 and 150 mg/kg) caused a significant increase in the 
first seizure latency in the PTZ-receiving rats (P < 0.001). The first seizure latency was significantly 
higher in the diazepam group than in the PTZ group (P < 0.001), and significantly lower in the 
flumazenil + extract (150 mg/kg) group than in the group receiving the extract (150 mg/kg) (P <0.001), 
but no significant difference was observed between the flumazenil + extract (150 mg/kg) group and 
the PTZ group (Figure 2). 
3.3. The frequency of head ticks  
Treatment with A. officinarum extract (100 and 150 mg/kg) and diazepam produced no significant 
effect on the total frequency of head ticks in the PTZ-receiving rats. (Figure 3). 
3.4. The total frequency of the entire body seizures 
Treatment with diazepam + the extract (50, 100 and 150 mg/kg) in the PTZ-receiving rats 
significantly reduced the total frequency of the entire body seizures (P < 0.001). The total frequency 
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of the entire body seizures was significantly higher in the flumazenil + extract (150 mg/kg) group than 
in the extract (150 mg/kg) group (P < 0.001), but was not significantly different compared to the PTZ-
receiving group (Figure 4). 
 
Figure 1. The survival percentage in different groups. # significant difference compared 
to pentylenetetrazol-receiving group (P < 0.05). 
 
Figure 2. First seizure latency in different groups. ###Significant difference when 
compared to pentylenetetrazole receiving group (P <0.001); ## Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.01). 
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Figure 3. The total frequency of head ticks in different groups. 
 
Figure 4. The total frequency of the entire body seizures in different groups. ## Significant 
difference compared to pentylenetetrazol-receiving group (P < 0.01); ### Significant 
difference compared to pentylenetetrazol-receiving group (P < 0.001) (150 mg/kg)  
(P < 0.001). 
3.5. The total frequency of tonic seizures 
The total frequency of tonic seizures was not significantly different between the extract (100 and 150 
mg/kg)-receiving groups and the PTZ-receiving group. The frequency of tonic seizures was significantly 
lower in the diazepam-receiving group than in the PTZ-receiving group (P < 0.05) (Figure 5). 
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3.6. The total frequency of repeated spinning and jumping 
Treatment with diazepam + extract (50, 100 and 150 mg/kg) caused a significant decrease in the 
total frequency of repeated spinning and jumping in the PTZ-receiving rats (P <0.01). Repeated 
spinning and jumping was significantly higher in the flumazenil + extract (150 mg/kg) group than in 
the extract group (150 mg/kg) (P < 0.01) (Figure 6). 
3.7. Immobility time in TST 
Immobility time was significantly lower in the control group than in the PTZ-receiving group (p 
<0.001). Treatment with diazepam + extract (50, 100, and 150 mg/kg) caused a significant decrease in 
immobility time in the PTZ-receiving rats (P < 0.01) (Figure 7). 
 
Figure 5. The total frequency of tonic seizures in different groups. #Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.05). 
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Figure 6. The total frequency of repeated spinning and jumping in different groups. ### 
Significant difference compared to pentylenetetrazol-receiving group (P < 0.001); ## 
Significant difference compared to pentylenetetrazol-receiving group (P < 0.01); 
#Significant difference compared to pentylenetetrazol-receiving group (P < 0.05). 
 
Figure 7. Immobility time in tail suspension test in different groups. ### Significant 
difference compared to pentylenetetrazol-receiving group (P < 0.001); ## Significant 
difference compared to pentylenetetrazol-receiving group (P < 0.01). 
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3.8. Initial latency in shuttle box test 
Initial latency was significantly different between the control group and PTZ-receiving group  
(P < 0.05). Initial latency was lower in the PTZ + extract (150 mg/kg)-treated group and diazepam 
group than in the PTZ-treated group (P < 0.05) (Figure 8). 
3.9. Secondary latency in shuttle box test 
Secondary latency was significantly higher in the control group than in the PTZ-receiving group 
(P < 0.001). Treatment with diazepam + extract (100 and 150 mg/kg) caused a significant increase in 
secondary latency in the PTZ-receiving rats (P < 0.001) (Figure 9). 
3.10. Serum antioxidant capacity 
Serum antioxidant capacity was significantly higher in the control group than in the PTZ-
receiving group (P < 0.001). Treatment with diazepam + extract (100 and 150 mg/kg) significantly 
increased serum antioxidant capacity in rats receiving PTZ (P <0.001). Serum antioxidant capacity 
was significantly lower in the flumazenil + extract (150 mg/kg)-receiving group than in the extract 
(150 mg/kg)-receiving group (P < 0.001), but there was no significant difference in serum antioxidant 
capacity was observed between the flumazenil + extract (150 mg/kg)-receiving group and the PTZ-
receiving group (Figure 10). 
 
Figure 8. Initial latency in the shuttle box test in different groups. #Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.05). 
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Figure 9. Secondary latency in shuttle box test in different groups. ### Significant 
difference compared to pentylenetetrazol-receiving group (P < 0.001). 
 
Figure 10. Serum antioxidant capacity in different groups. ### Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.001); ## Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.01). 
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3.11. Serum MDA level 
Serum MDA level was significantly lowers in the control group than in the PTZ-receiving group 
(P < 0.001). Treatment with diazepam + extract (50, 100 and 150 mg/kg) caused a significant decrease 
in serum MDA level in the PTZ-receiving rats (P < 0.001). The serum MDA level was significantly 
lower in the flumazenil + extract (150 mg/kg)-receiving group than in the extract (150 mg/kg)-
receiving group (P < 0.001), but was not significantly different compared to that in the PTZ-receiving 
group (Figure 11). 
3.12. Brain antioxidant capacity 
The antioxidant capacity was significantly higher in the control group than in the PTZ-receiving 
group (P < 0.001). Treatment with diazepam, extract (100 and 150 mg/kg) caused a significant increase 
in the brain antioxidant capacity in the PTZ-receiving rats (P < 0.01, P < 0.05). The brain antioxidant 
capacity was significantly lower in the flumazenil + extract (150 mg/kg)-receiving group than in the 
extract (150 mg/kg)-receiving group (P < 0.001), but was not significantly different compared to that 
in the PTZ-receiving group (Figure 12). 
3.13. Brain MDA levels 
MDA was significantly lower in the control group than in the PTZ-receiving group (P <0.001). 
Treatment with diazepam, extract (50, 100 and 150 mg/kg) caused a significant decrease in brain MDA 
level in the PTZ-receiving group (P < 0.001). Brain MDA level was significantly lower in the 
flumazenil + extract (150 mg/kg)-receiving group than in the extract (150 mg/kg)-receiving group and 
the diazepam-receiving group (P < 0.001) (Figure 13). 
 
Figure 11. Serum malondialdehyde levels in different groups. ### Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.001). 
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Figure 12. Brain antioxidant capacity in different groups. ### Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.001); ## Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.01); #Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.05). 
 
Figure 13. Brain malondialdehyde levels in different groups. ### Significant difference 
compared to pentylenetetrazol-receiving group (P < 0.001). 
4. Discussion 
Given high prevalence of epilepsy worldwide and low efficacy of synthetic drug, it is essential to 
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rhizome on the severity of epilepsy and memory impairment in rats with pentylenetetrazole (PTZ)-
induced kindling. The results showed that A. officinarum extract (100 and 150 mg/kg) caused a 
significant increase in first seizure latency, and treatment with this extract at 50, 100 and 150 mg/kg 
significantly reduced the total frequency of the entire body seizures and frequent spinning and jumping 
in the PTZ-receiving rats, but did not significantly affected the total frequency of head ticks, the 
seizures of head and upper limbs, and tonic seizures. First seizure latency was significantly lower in 
the flumazenil + extract (150 mg/kg)-receiving group than in the extract (100 and 150 mg/kg)-
receiving groups, but was not significantly different between the flumazenil + extract (150 mg/kg)-
receiving group and PTZ-receiving group. The total frequency of the entire body seizures and frequent 
spinning and jumping were significantly higher in the flumazenil + extract (150 mg/kg)-receiving 
group than in the groups receiving extract at 50, 100 and 50 mg/kg, but was not significantly different 
between the flumazenil + extract (150 mg/kg)-receiving group and the PTZ-receiving group. Survival 
rates in rats receiving PTZ (50 mg/kg) and those treated with the extract (50, 100, and 150 mg/kg) 
were 90%, 100%, and 100%, respectively. In the present study, diazepam treatment increased first 
seizure latency and decreased the total frequency of the entire body seizures and frequent spinning and 
jumping significantly. Studies have reported that the GABAergic, glutaminergic and cholinergic 
systems are involved in epilepsy [12]. The inhibition of GABA secretion has been observed in PTZ-
induced seizure. GABA agonists can reduce the severity and duration of seizures. In addition, GABA 
synthesis inhibitors can cause seizure. Diazepam is a GABA agonist and, as shown in previous studies, 
decreases the severity and symptoms of seizure in animals and humans. In the present study, treatment 
with flumazenil (GABA receptor antagonist) significantly inhibited the anticonvulsant effects of this 
extract in rats receiving A. officinarum extract (150 mg/k), which indicates that the extract activity is 
exerted via the GABAergic system. Acetylcholine and its nicotinic receptors are involved in the 
stimulation and maintenance of seizures, so that induction of epilepsy by parenteral lithium, 
pilocarpine, and kinate significantly increases the levels of acetylcholine in the cortex and 
hippocampus [3]. In addition, it has been argued that some mutations in the subtypes of nicotinic 
acetylcholine receptors play a role in the development of certain types of epilepsy [13]. It has been 
reported that the inhibition of acetylcholinesterase significantly increases the incidence rate of 
spontaneous seizure [14]. Köse et al. showed that acetylcholinesterase obtained from A. officinarum 
has anticholinergic and inhibitory properties [8]. It can be argued that the extract of the plant can reduce 
the severity of epileptic seizures in rats through exerting anticholinergic activity; however, this 
hypothesis deserves further investigation. Various compounds have been identified in A. officinarum 
rhizome by chromatographic techniques, including 8.1-cineol, methyl cinnamate, galangin, 3-o-methyl 
galangin, kaemferide, alpinin, galangol, and diarylheptanoid. Galangin and 3-O-methyl galangin are two 
main compounds of A. officinarum rhizome. Galangan is a flavonoid that is found in large quantities in 
A. officinarumrhizome. A. officinarum has anti-inflammatory and antioxidant properties [11]. Guo et al. 
studied the anticholinergic effects of 25 flavonoids isolated from different medicinal plants. They 
reported that A. officinarum, among the studied flavonoids, had the most potent effects on 
acetylcholinesterase [15]. 
The role of oxidative stress in the onset and progression of epileptic seizures has already been 
demonstrated [16]. In a study conducted in 50 patients with epilepsy, lipid peroxidation and hemolysis 
percentage of the erythrocytes were significantly higher in patients with epilepsy than in healthy 
subjects. The levels of glutathione reductase and vitamins C, E, and A in the erythrocytes were 
significantly lower in patients with epilepsy than in healthy subjects [17]. Animal studies have shown 
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that PTZ-induced epileptic seizures lead to production of free radicals and oxidative damage to proteins, 
lipids, and cell DNA. The high levels of mitochondrial superoxide, the inactivation of iron and sulfur-
dependent enzymes such as aconitase, and iron-induced toxicity may contribute to oxidative damage 
to neurons following epileptic seizures [16]. In the present study, serum and brain antioxidant capacity 
was significantly lower in the PTZ-receiving group than in the control group. In addition, serum and 
brain MDA levels were significantly higher in the PTZ-receiving group than in the control group, 
indicating a decrease in the serum and tissue antioxidant capacity and lipid peroxidation as well as an 
increase in epileptic seizures.  In the present study, different concentrations of A. officinarum extract 
caused a significant increase in antioxidant capacity and a decrease in serum MDA levels in rats treated 
with PTZ. In addition, the subsequent flumazenil treatment resulted in a significant increase in lipid 
peroxidation and reduction in antioxidant capacity, suggesting that flumazenil inhibits damage to the 
neurons by preventing anticonvulsant effects of the plant. In addition, studies have reported that A. 
officinarum and 3-o-methyl galangin are two major compounds of A. officinarum rhizome with 
antioxidant properties [11]. Experimental studies have shown that the induction of epilepsy in rodents 
causes a significant increase in inflammation mediators in the epilepsy-affected regions [18,19]. High 
levels of inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-6, in the 
astrocytes can reduce seizure threshold and the frequency of spontaneous seizures. Experimental 
studies on animal models have revealed that anti-inflammatory drugs can reduce the severity of certain 
types of epilepsy [19]. It was reported that the levels of inflammatory cytokines including tumor 
necrosis factor alpha, interleukin-6, and interleukin-1 beta as well as interleukin-1 receptor antagonist 
significantly increased in patients with epilepsy [20]. The compounds with anti-inflammatory effects 
can help decrease the severity of epileptic seizures. The anti-inflammatory effects of A. officinarum 
have already been demonstrated. For example, Yadav et al. reported that A. officinarum extract 
treatment significantly reduced nitric oxide production due to stimulation by lipopolysaccharide in 
macrophage cell line in rats [21]. Treatment of the mononuclear cells of human peripheral blood with 
A. officinarum extract significantly reduced the production of the inflammatory cytokines interleukin-
1 beta and tumor necrosis factor alpha due to stimulation by lipopolysaccharide [22]. The study of Lee 
et al. showed that the ethanolic extract of A. officinarum rhizome significantly reduced edema volume 
in carrageenan-induced arthritis model [21]. Studies have shown that galangin found in A. officinarum 
rhizome has anti-inflammatory effects [11]. It can be argued that A. officinarum extract prevents 
damage to the neurons and associated disorders by decreasing the levels of inflammation mediators.  
In the present study, in the shuttle box test, the secondary latency was significantly higher in the control 
group than in the PTZ-receiving group, suggesting a decline in passive avoidance memory in seizure 
in rats. Treatment with diazepam and A. officinarum (100 and 150 mg/kg) in the PTZ-receiving rats 
caused a significant increase in the secondary latency. Cognitive disorders frequently occur in patients 
with epilepsy. In addition, epilepsy can disrupt cognitive processes; common antiepileptic drugs also 
disrupt cognitive processes, which lead to a significant decline in quality of life.  Epileptic seizures are 
associated with damage to neurons in the limbic system including CA3, CAL, hippocampal torsion, 
amygdala, and entorhinal cortex. Damage to the neurons in the hippocampus causes memory and 
learning impairment. The role of the hippocampus as a system involved in memory processes has been 
well explained, and damage to this region of the brain can cause severe forgetfulness. Agarwal et al. 
reported that PTZ-induced epilepsy in rats caused impairment of passive avoidance memory and 
significantly reduced latency to enter the dark chamber in the shuttle box test, which is consistent with 
our results. In addition, studies have reported that PTZ-induced epileptic seizures cause spatial memory 
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impairment, learning disorders, and passive avoidance memory in laboratory animals [23]. In the 
present study, A. officinarum extract significantly improved passive avoidance memory in rats 
receiving PTZ. It can be argued that galangan extract prevents memory loss by preventing damage to 
tissues involved in memory and learning. Yongfang et al. reported that A. officinarum, which is the 
main flavonoid compound of A. officinarum rhizome, significantly prevented memory loss and passive 
avoidance memory due to d-galactose. They reported that A.officinarum exerted protective  effects on 
the central nervous system by reducing oxidative stress parameters and increasing the activity of the 
NA+-ATPase and K+-ATPase channels [24]. In the present study, immobility time in the TST was 
significantly lower in the control group than in the PTZ-receiving group, suggesting the induction of 
depression due to epileptic seizures. In addition, treatment with diazepam and A. officinarum extract 
(50, 100 and 150 mg/kg) significantly reduced the immobility time in the PTZ-receiving rats. It has 
been reported that the prevalence of depression is significantly higher in patients with epilepsy than in 
the general population [24]. Depression is a serious healthcare and social problem in patients suffering 
from epilepsy that affects their quality of life. Depression affects almost half of the patients under 
treatment for epilepsy. It has been reported that loss of occupation and social activity exacerbates 
depression in patients with epilepsy [25]. We choose diazepam as a positive control group 
(anstablished drug used to treat epilepsy with partially determined underlying mechanism of action 
mostly via GABAergic system. There are several pattern and mechanism of the seizure and agent may 
affected one or more pathway based on this affect the potency and efficacy of favorite agent are 
difficult. The present work is the first work to show that PTZ treatment in rats caused depression-
related behaviors, and treatment with A. officinarum extract caused a significant improvement of these 
behaviors. According to our findings, A. officinarum extract can be used as an adjuvant agent along 
with commercial drugs to treat epilepsy. 
5. Conclusion 
According to the results of the current study, treatment with A. officinarum extract in the PTZ-
receiving rats significantly increased first seizure latency and reduced the frequency of the entire body 
seizures and frequent spinning and jumping. Flumazenil treatment in A. officinarum extract (150 
mg/kg)-receiving rats significantly inhibited anticonvulsant effects of the extract. Treatment with A. 
officinarum extract in PTZ-receiving rats significantly increased passive avoidance memory in the 
shuttle box test and reduced immobility time in the TST. A. officinarum extract can be used to reduce 
the severity of epileptic seizures and improve learning disorders and associated mood disorders. 
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